[Fundamental study on the treatment of retinitis pigmentosa].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000627:therapeutic use; D000818:Animals; D000931:Antidotes / Q000627:therapeutic use; D001001:Anura; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004596:Electroretinography; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D008027:Light; D008055:Lipids / Q000494:pharmacology; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000627:therapeutic use; D008875:Middle Aged; D010545:Peroxides / Q000494:pharmacology; D010649:Phenylalanine / Q000378:metabolism; D051381:Rats; D012038:Regeneration; D012110:Reserpine / Q000627:therapeutic use; D012162:Retinal Degeneration / Q000503:physiopathology; D012168:Retinal Pigments / Q000096:biosynthesis; D012174:Retinitis Pigmentosa / Q000188:drug therapy* / Q000378:metabolism; D013747:Tetrabenazine / Q000627:therapeutic use; D014443:Tyrosine / Q000378:metabolism / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000596:Amino Acids; D000931:Antidotes; D006728:Hormones; D008055:Lipids; D010545:Peroxides; D012168:Retinal Pigments; D014665:Vasodilator Agents; D014815:Vitamins; D014443:Tyrosine; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D009074:Melanocyte-Stimulating Hormones; D013747:Tetrabenazine